Analyst Ratings for Adial Pharmaceuticals Inc (ADIL)

ADIL Rating Summary

ADIL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ADIL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.33 (+40.1%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/3/2026 Alliance Global Partners James Molloy New Coverage Buy
(N/A)
11.00
(N/A)
3.34
(5.95)
78.14% Details
6/15/2026 Lucid Capital Markets Elemer Piros New Coverage Buy
(N/A)
6.00
(N/A)
2.98
(5.95)
99.66% Details